Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB

Fetil E., İLKNUR T., Altiner D. D., Ozkan S., Gunes A.

JOURNAL OF DERMATOLOGY, vol.32, no.11, pp.868-874, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 11
  • Publication Date: 2005
  • Doi Number: 10.1111/j.1346-8138.2005.tb00863.x
  • Journal Name: JOURNAL OF DERMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.868-874
  • Keywords: calcipotriol, clobetasol, tretinoin, UVB, MED, TOPICALLY APPLIED SUBSTANCES, ULTRAVIOLET-LIGHT, SALICYLIC-ACID, PHOTOTHERAPY, ERYTHEMA, THERAPY, PSORIASIS, SKIN
  • Dokuz Eylül University Affiliated: Yes

Abstract

Various studies have shown the blocking effects of topical agents on UVB penetration, which can be used in combination with phototherapy. In this study, the photoprotective effects of 0.005% calcipotriol, 0.05% clobetasol-17-propionate, and 0.1% tretinoin, which can be used in combination with broad-band UVB, were investigated in an in vivo test. In a study group of 20 patients, phototests were performed to determine minimal erythema doses (MED) and the tests were repeated with thin (0.1 cc/25 cm(2)) and thick (0.3 cc/25 cm(2)) calcipotriol, clobetasol-17-propionate, and tretinoin in cream forms and sunscreen. After determining the MED, the test was repeated in another 20 patients with thin and thick calcipotriol and clobetasol-17-propionate in both cream and ointment forms and sunscreen. MED was increased with thin and thick applications of all agents. Moreover, the photoprotective effects of each agent increased with their thick applications compared with thin ones. The application of calcipotriol cream and ointment, clobetasol cream and ointment, and tretinoin cream, all of which can block UVB, is not recommended just before phototherapy.